• A Headlands Research Site   
    Headlands Research White Logo
    • About Headlands Research
    • Capabilities
    • Site Network
    • Team
Toronto Memory Program
  • Facebook
  • Twitter
  • LinkedIn
Donate Now
  • About Us
    • Medical Director
    • Our Team
    • Our Facility
    • Careers
  • Patients
    • Memory Clinic
    • Movement Disorders Clinic
    • Free Memory Assessment
    • Frequently Asked Questions
    • Clinical Trials
  • Physicians
  • Sponsors
  • Clinical Trials
    • Current Studies
    • Free Memory Assessment
    • Frequently Asked Questions
  • Media
  • Contact

Media

 

Assessing Lecanemab’s Effect in Early Alzheimer Disease: Sharon Cohen, MD, FRCPC

Dr. Sharon Cohen, a neurologist and assistant professor at the University of Toronto provided insight on positive topline findings from the phase 3 Clarity AD study of lecanemab in early Alzheimer disease.

To hear this discussion, click on the link below.

https://www.neurologylive.com/view/assessing-lecanemab-effect-in-early-alzheimer-disease-sharon-cohen

Recent Posts

  • Hope and anxiety surround new Alzheimer’s drug lecanemab
  • Experimental drug appears to slow progression of Alzheimer’s disease in clinical trial but raises safety concerns
  • A New Drug Could Slow Alzheimer’s Disease, Data Show
  • A potential breakthrough in Alzheimer’s research needs Canadians’ help to move forward
  • An experimental Alzheimer’s drug could be approved next year. But it comes with risks
  • Ontario not ready for new Alzheimer’s treatment
  • Assessing Lecanemab’s Effect in Early Alzheimer Disease: Sharon Cohen, MD, FRCPC
  • Dr. Sharon Cohen on Medcan’s podcast series called Eat, Move, Think!
  • Dr. Sharon Cohen on CanadaTalks with Matt Gurney
  • CTV News Channel with Dr. Sharon Cohen on FDA approval of Aducanumab

Media Requests

If your organization would like to make a request, please use one of the following two options:

  • Call: (416) 386-9761 Ext. 364
  • Email: media@memorydisorders.ca
Latest Tweets

Discover Alzheimer's prevention with Dr. Sharon Cohen!
📅 Nov 15, 2023 ⏰ 6:30 PM EST
📍 Ontario Science Centre
🔍 Highlights: ...Limited Genetic Testing, Free Memory Testing Signup
Join us! Register today!

Image for twitter card

Alzheimer's Disease Prevention

Explore a Preventable Future: Join Dr. Sharon Cohen at the Ontario Science Centre for Alzheimer's Prevention Strategies.

www.eventbrite.ca

Reply on Twitter 1704840425792544960 Retweet on Twitter 1704840425792544960 0 Like on Twitter 1704840425792544960 0 Twitter 1704840425792544960

Don't miss this insightful article on the challenges of dementia diagnosis! Dr. Sharon Cohen, Medical Director of Toronto Memory Program, ...shares her expertise on why getting the right diagnosis matters and how you can advocate for yourself.

Image for twitter card

Misdiagnosed: Why Is a Dementia Diagnosis So Hard to Get Right?

When it comes to dementia, it takes most patients years to get an accurate diagnosis. Why is dementia so hard to diagnose?

www.beingpatient.com

Reply on Twitter 1701950024349839723 Retweet on Twitter 1701950024349839723 0 Like on Twitter 1701950024349839723 1 Twitter 1701950024349839723
Load More...
Toronto Memory Program

A Headlands Research Company

  • Facebook
  • Twitter
  • LinkedIn
  • About Us
  • Patients
  • Physicians
  • Sponsors
  • Studies
  • In the Media
  • Contact Us


Monday - Friday: 8am - 4pm


Headlands Research Logo



© 2023 Toronto Memory Program. All rights reserved.